©2024 Stanford Medicine
Endurant Stent Graft System Post Approval Study (ENGAGE PAS)
Not Recruiting
Trial ID: NCT01379222
Purpose
The purpose of the study is to demonstrate the long term safety and effectiveness of the
Endurant Stent Graft System for the endovascular treatment of infrarenal abdominal aortic
aneurysms in a post-approval environment, through the endpoints established in this protocol.
The clinical objective of the study is to evaluate the long term safety and effectiveness of
the Endurant Stent Graft System assessed at 5 years through freedom from Aneurysm-Related
Mortality (ARM).
Official Title
Post Approval Study Evaluating the Long Term Safety and Effectiveness of the Endurant Stent Graft System (ENGAGE PAS)
Stanford Investigator(s)
Ronald L. Dalman MD
Dr. Walter C. Chidester Professor
E. John Harris Jr.
Professor of Surgery (Vascular), Emeritus
Eligibility
Inclusion Criteria:
- Age ≥18 years
- Indication for elective surgical repair of abdominal aortic aneurysm (AAA) with an
endovascular stent graft in accordance with the applicable guidelines on endovascular
interventions and the Instructions for Use of the Endurant Stent Graft System
- Signed consent form. The subject or legal representative has been informed of the
nature of the trial and has consented to participate and authorized the collection and
release of his medical information
- Intention to electively implant the Endurant Stent Graft System
- Ability and willingness to comply with the Clinical Investigational Plan (CIP).
Exclusion Criteria:
- High probability of non-adherence to physician's follow-up requirements
- Current participation in a concurrent trial which may confound study results
- Female of childbearing potential in whom pregnancy cannot be excluded or who is
lactating.
Intervention(s):
device: Endurant Stent Graft System
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Ronald Dalman
6507255227